News

ValoTx

Valo Therapeutics Announces First Patient Dosed with PeptiCRAd-1 – Innovative Immuno-oncology 

26/06/2023
Read more
ValoTx

Nordic Life Sciences Interview: Valo Therapeutics CEO Paul Higham

24/10/2022
Read more
ValoTx

Valo Immuno-Oncology Treatment

09/08/2022
Read more
ValoTx

Valo Therapeutics Oy Shareholder Update 

05/08/2022
Read more
ValoTx

Valo Introduction Video

04/08/2022
Read more